Search
Alamar Biosciences Ord Shs
ALMRAdd to Watchlist
34.850USD
+2.840+8.87%
Close 09-18 16:00（ET）
2.42BMarket Cap
0.00P/E TTM
Alamar Biosciences Ord Shs (ALMR) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to Alamar Biosciences Ord Shs in the past month.
Buy
2 Strong Buy
2 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
33.000USD+3.09%
ALMR Analyst Recommendation Trends
In the current month, ALMR has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ALMR average Analyst price target in the last month is 33.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
2
2
0
0
0
0
0
0
2
2
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
0
0
0
0
0
0
ALMR Analyst Rating for Peer Comparison
Updated: Sep 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
13
9
1
0
34
Boston Scientific Corp
BSX
11
17
6
0
0
34
Thermo Fisher Scientific Inc
TMO
10
16
6
0
0
32
Edwards Lifesciences Corp
EW
10
14
8
0
0
32
Veeva Systems Inc
VEEV
7
15
8
1
0
31
Danaher Corp
DHR
11
13
4
0
0
28
Waters Corp
WAT
8
10
9
0
0
27
Agilent Technologies Inc
A
6
11
7
0
0
24
Illumina Inc
ILMN
5
7
7
2
1
22
Resmed Inc
RMD
2
7
10
1
1
21
Financial Forecasting
Based on analysts' estimates, ALMR EPS is projected to reach -0.214 in FY2026Q3, following reported EPS of -0.190 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
--
--
-0.33
-0.21
-0.21
Actual
-0.45
-0.32
-0.19
--
--
Surprise
--
--
+41.65%
--
--
FAQs
What is Alamar Biosciences Ord Shs's price target?
Analysts forecast that Alamar Biosciences Ord Shs's price target is USD 33.00, with the highest forecast at USD 35.00 and the lowest forecast at USD 31.00.
What is the analyst rating for Alamar Biosciences Ord Shs?
Based on the ratings of Alamar Biosciences Ord Shs's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.